Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.
Level 5 - mechanism / opinion, no new human data
Bench research using in vitro human hepatocytes and in vivo laboratory models
PubMed 23112875 · doi:10.1371/journal.pone.0047948
What was done
Researchers examined the mechanism by which uric acid influences fructokinase (KHK) expression and fructose-induced lipogenesis using cultured human hepatocytes in vitro and an animal model in vivo. They tested whether inhibiting uric acid production blocked fructose-induced triglyceride accumulation and investigated the transcriptional mechanism involving ChREBP binding to the KHK promoter.
What was found
The abstract reports no numeric values, percentages, or confidence intervals. Experimentally, uric acid up-regulated KHK expression in human hepatocytes, which amplified fructose-induced lipogenesis. Inhibition of uric acid production markedly blocked fructose-induced triglyceride accumulation in vitro and in vivo. Mechanistically, uric acid stimulated KHK expression through activation of the transcription factor ChREBP, which bound to a specific sequence within the KHK promoter.
Why it matters
This paper identifies a positive feedback loop where uric acid produced during fructose phosphorylation upregulates fructokinase via ChREBP, suggesting a mechanistic link between hyperuricemia and individual sensitivity to fructose-induced fatty liver.
Limits
The study is limited to preclinical bench and animal research without direct clinical testing in human subjects. The abstract omits sample sizes, specific animal species/models, drug doses, and quantitative effect sizes or statistical measures.
Cited by
- context Fructose depletes mitochondrial ATP production in the liver.
- supports Fructose is phosphorylated to fructose-1-phosphate in the liver, depleting ATP to ADP and AMP, which is subsequently converted into uric acid.
- supports Hepatic fructose metabolism consumes ATP without a phosphate-scavenging pathway to return it, driving conversion of AMP into uric acid.